Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2020 - Issue 6

Formulation and Evaluation of Ziprasidone HCl Oral Controlled Release Matrix Download PDF


Muhammad Mustafa Swaleh (Pharm. D), Zeb-un-Nisa, Syed Imran Ali, Maqsood Ahmed Khan, Mehwish Rizvi, Saira Shahnaz, Rasheeda Fatima, Sadia Suri Kashif, Najeeb Khatian, Ijaz Ali
Abstract

The aim of the present study was to formulate a controlled release Ziprasidone HCl oral matrix tablet using different proportions of hydroxyl propyl methylcellulose (HPMC) K15M to minimize dosing frequency. Matrix tablets were prepared with various proportions of HPMC by direct-compression to upgrade their compliance and safety profile. Micromeritic properties of blends, physical evaluation of tablets, swelling, and dissolution studies were performed to optimize the formulation. The drug release profile indicated the controlled release pattern of formulation with HPMC K15M 50% for 24 hours effectively. Ziprasidone CR matrix-based tablet was formulated successfully and it was shown that the release of drugs could be controlled by the inclusion of different ratios of various viscosity grade polymers.

Cite this article
(Pharm D) M M S, Zeb-un-Nisa, Ali S I, Khan M A, Rizvi M, Shahnaz S et al. Formulation and Evaluation of Ziprasidone HCl Oral Controlled Release Matrix . Pharmacophore 2020;11(6):41-7

QR code:

Short Link:
Quick Access

Pharmacophore
ISSN: 2229-5402


Pharmacophore
© 2021 All rights reserved